Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. | Apnimed’s star sleep apnea ...

A sleep apnea drug is already available in the ... gut receptors to spark metabolic effects, such as weight loss. The way Zepbound works to treat OSA is unknown, but obesity is a risk factor ...

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

This proves that Eli Lilly's obesity drug Zepbound, as a GLP-1/GIP agonist, is far more capable of delivering weight loss compared ... and for obstructive sleep apnea. According to the 10-Q ...

Prediabetes is a clinical inflection point and a modifiable risk state. Small shifts in care can translate to big shifts in ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...